The Effectiveness of Topical Silver Colloid in Treating Patients With Recalcitrant Chronic Rhinosinusitis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

December 10, 2015

Primary Completion Date

March 6, 2016

Study Completion Date

April 8, 2017

Conditions
Rhinosinusitis
Interventions
DRUG

Silver Colloid

Topical silver colloid will be administered for 6 weeks. This will either occur before topical saline nasal spray. Participants are randomized as to the order of sprays. The commercially available silver colloid product, Sovereign Silver Mineral Supplement, will be used.

OTHER

Saline

Topical saline will be administered for 6 weeks. This will occur before the topical silver colloidal nasal spray. Participants are randomized as to the order of sprays.

Trial Locations (2)

N6A 4V2

Saint Joseph's Health Care, London

Unknown

St. Joseph's Health Care, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT02403479 - The Effectiveness of Topical Silver Colloid in Treating Patients With Recalcitrant Chronic Rhinosinusitis | Biotech Hunter | Biotech Hunter